SCHEMBL5160091

SCHEMBL5160091

CCCCCCCCC([C]=O)CC

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.43
GPR84 Q9NQS5 5/20 0.40
FDPS P14324 3/20 0.40
FFAR1 O14842 1/20 0.40
LMNA P02545 1/20 0.39
LCK P06239 1/20 0.39
PPARD Q03181 1/20 0.39
ZDHHC20 Q5W0Z9 1/20 0.39
ZDHHC2 Q9UIJ5 1/20 0.39
DNM1 Q05193 1/20 0.39
TSHR P16473 1/20 0.38
THRB P10828 1/20 0.38
ADH1B P00325 1/20 0.38
ADH1C P00326 1/20 0.38
ADH1A P07327 1/20 0.38
ADH4 P08319 1/20 0.38
ADH7 P40394 1/20 0.38
LAP3 P28838 1/20 0.38
CA2 P00918 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL137130 1.00 MAPT (0.43) MAPTGPR84FDPSFFAR1LMNA
SCHEMBL9233916 1.00 MAPT (0.43) MAPTGPR84FDPSFFAR1LMNA
SCHEMBL6587420 1.00 MAPT (0.43) MAPTGPR84FDPSFFAR1LMNA
SCHEMBL8648044 1.00 MAPT (0.43) MAPTGPR84FDPSFFAR1LMNA
SCHEMBL8646134 1.00 MAPT (0.43) MAPTGPR84FDPSFFAR1LMNA
SCHEMBL5154559 1.00 MAPT (0.43) MAPTGPR84FDPSFFAR1LMNA
SCHEMBL8647947 1.00 MAPT (0.43) MAPTGPR84FDPSFFAR1LMNA
SCHEMBL8647983 1.00 MAPT (0.43) MAPTGPR84FDPSFFAR1LMNA
SCHEMBL8650122 1.00 MAPT (0.43) MAPTGPR84FDPSFFAR1LMNA
SCHEMBL1410679 1.00 MAPT (0.43) MAPTGPR84FDPSFFAR1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10882941-B2 Initiator mixture, composition, the use thereof, polyol polymer preparation method, and polyol polymer obtained by the method ARKEMA FRANCE (FR) 2021-01-05 US claimed
US-20180258211-A1 INITIATOR MIXTURE, COMPOSITION, THE USE THEREOF, POLYOL POLYMER PREPARATION METHOD, AND POLYOL POLYMER OBTAINED BY THE METHOD ARKEMA FRANCE (FR) 2018-09-13 US claimed
WO-2021083949-A1 BIFUNCTIONAL COMPOUNDS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2021-05-06 WO disclosed
US-10882941-B2 Initiator mixture, composition, the use thereof, polyol polymer preparation method, and polyol polymer obtained by the method ARKEMA FRANCE (FR) 2021-01-05 US disclosed
US-20180258211-A1 INITIATOR MIXTURE, COMPOSITION, THE USE THEREOF, POLYOL POLYMER PREPARATION METHOD, AND POLYOL POLYMER OBTAINED BY THE METHOD ARKEMA FRANCE (FR) 2018-09-13 US disclosed
EP-1742662-A2 COMBINATION OF PROSTAGLANDIN E2 RECEPTOR ANTAGONISTS AND RENIN-ANGIOTENSIN SYSTEM INHIBITORS FOR TREATING RENAL DISEASES Astellas Pharma Inc. (JP) 2007-01-17 EP disclosed
WO-2005105147-A2 COMBINATION OF PROSTAGLANDIN E2 RECEPTOR ANTAGONISTS AND RENIN-ANGIOTENSIN SYSTEM INHIBITORS FOR TREATING RENAL DISEASES ASTELLAS PHARMA INC. (JP) 2005-11-10 WO disclosed
EP-1572135-A2 MILD SURFACTANT COMPOSITIONS Henkel Kommanditgesellschaft auf Aktien (DE) 2005-09-14 EP disclosed
WO-2004054522-A2 MILD SURFACTANT COMPOSITIONS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2004-07-01 WO disclosed
EP-0094343-A1 Polyalkylpiperidine derivatives containing isocyanate groups CIBA-GEIGY AG (CH) 1983-11-16 EP disclosed